The U.S. Food and Drug Administration’s approval process for non-combustible nicotine products has slowed to a near standstill, according to industry and policy sources. This regulatory paralysis persists despite shifting scientific evidence on harm reduction and a sharp, sustained decline in youth usage rates for products like e-cigarettes and nicotine pouches. The internal dynamics preventing action point to a significant policy split within the administration and a personal reluctance by the agency’s commissioner to authorize new products.
Public health data consistently identifies smoking as a leading cause of preventable death. The current regulatory inaction delays the transition away from combustible tobacco for adult smokers, a transition that many public health experts argue could save lives. The stalemate has also fueled the growth of an illicit market for vaping products, which operates without quality control or oversight.
Read Full Article: https://www.naturalnews.com/2026-04-18-stalemate-fda-approval-lower-risk-nicotine-products.html
